Original Articles

All Items

In general, this kind of publication should be divided into an Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions and References. [3500 words max, abstract 180 words max, 30 references max, 3/5 tables and/or figures]

“Living under the sword of Damocles”: a psychological support project for patients with immune thrombocytopenia and their caregivers

Giuseppe Auteri, Laura Ricci, Nicola Vianelli, Barbara Lovrencic

https://doi.org/10.4081/btvb.2025.161

138

PDF: 50

Appendix A: 28

Appendix B: 29
Welcome to the 12^th International Conference on Thrombosis and Hemostasis Issues in Cancer!

Anna Falanga, Benjamin Brenner, Alok A. Khorana

https://doi.org/10.4081/btvb.2024.138

1314

PDF: 207
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

https://doi.org/10.4081/btvb.2024.111

1342

PDF: 253
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

https://doi.org/10.4081/btvb.2024.119

536

PDF: 191
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

https://doi.org/10.4081/btvb.2024.108

575

PDF: 220
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

https://doi.org/10.4081/btvb.2022.52

1940

PDF: 216
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

Gary E. Raskob

https://doi.org/10.4081/btvb.2024.124

499

PDF: 194
Restrained glycoprotein VI-induced platelet signaling by tyrosine protein phosphatases independent of phospholipase Cγ2

Jingnan Huang, Delia I. Fernández, Jinmi Zou, Xueqing Wang, Johan W.M. Heemskerk, Ángel García

https://doi.org/10.4081/btvb.2023.93

366

PDF: 130
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

https://doi.org/10.4081/btvb.2022.10

1009

PDF: 322

APPENDIX: 62
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

https://doi.org/10.4081/btvb.2022.50

772

PDF: 298
Platelet distribution width is associated with cardiovascular mortality in an adult general population

Benedetta Izzi, Simona Costanzo, Alessandro Gialluisi, Amalia De Curtis, Sara Magnacca, Teresa Panzera, Augusto Di Castelnuovo, Maria Benedetta Donati, Chiara Cerletti, Marc F. Hoylaerts, Giovanni de Gaetano, Licia Iacoviello, *on behalf of the Moli-sani Study Investigators

https://doi.org/10.4081/btvb.2023.83

1528

PDF: 253

Supplementary Material: 40
Plasma fibrinogen levels and all-cause and cause-specific mortality in an Italian adult population: results from the Moli-sani study

Roberta Parisi, Simona Costanzo, Romy de Laat-Kremers, Augusto Di Castelnuovo, Amalia De Curtis, Teresa Panzera, Mariarosaria Persichillo, Chiara Cerletti, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello, Bas de Laat , for the Moli-sani Study Investigators

https://doi.org/10.4081/btvb.2023.46

1549

PDF: 390

APPENDIX: 75
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?

Simon Noble

https://doi.org/10.4081/btvb.2024.125

1092

PDF: 151
Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

https://doi.org/10.4081/btvb.2025.155

113

PDF: 22
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

https://doi.org/10.4081/btvb.2024.113

405

PDF: 201
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

https://doi.org/10.4081/btvb.2023.84

1199

PDF: 269

Supplementary File: 144
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

https://doi.org/10.4081/btvb.2022.34

4499

PDF: 379

Supplementary Files: 109
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot

Rushad Patell, Jeffrey I. Zwicker, Rohan Singh, Simon Mantha

https://doi.org/10.4081/btvb.2024.123

1147

PDF: 242
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

https://doi.org/10.4081/btvb.2024.114

400

PDF: 138
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

https://doi.org/10.4081/btvb.2023.89

1936

PDF: 214

Supplementary Material: 41
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

https://doi.org/10.4081/btvb.2024.120

630

PDF: 270
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

https://doi.org/10.4081/btvb.2024.118

664

PDF: 260
Evaluation of Coaguchek<sup>®</sup>Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

Cristina Legnani, Michela Cini, Sophie Testa, Alberto Tosetto, Claudia Dellanoce, Stefania Bellesso, Giuseppe Carli, Ilaria Nichele, Laura Lissandrini, Serena Zorzi, Emilia Antonucci, Gualtiero Palareti

https://doi.org/10.4081/btvb.2022.37

1411

PDF: 286
Endothelial cell dysfunction in cancer: a not-so-innocent bystander

Betül Ünlü, Neha Joshi, Jamie M. O'Sullivan

https://doi.org/10.4081/btvb.2024.116

1116

PDF: 187
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

https://doi.org/10.4081/btvb.2023.92

751

PDF: 207
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

https://doi.org/10.4081/btvb.2022.41

2223

PDF: 232

Supplementary Files: 57
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

https://doi.org/10.4081/btvb.2022.12

4940

PDF: 287
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

https://doi.org/10.4081/btvb.2022.42

833

PDF: 274
Clinical and radiological characteristics of cerebral vein thrombosis: a retrospective study

Mosaad Almegren

https://doi.org/10.4081/btvb.2023.85

283

PDF: 135
Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

https://doi.org/10.4081/btvb.2022.36

1006

PDF: 213
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

https://doi.org/10.4081/btvb.2024.117

1665

PDF: 405
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth

https://doi.org/10.4081/btvb.2024.115

571

PDF: 185
Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

https://doi.org/10.4081/btvb.2023.59

520

PDF: 216
Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia

Anna Poretto, Elisabetta Borella, Giacomo Turatti, Michelangelo Marobin, Elena Campello, Daniela Tormene, Paolo Simioni, Luca Spiezia

https://doi.org/10.4081/btvb.2022.47

1130

PDF: 204
Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

Francesco Cicconi

https://doi.org/10.4081/btvb.2024.128

1215

PDF: 320
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

https://doi.org/10.4081/btvb.2022.19

4624

PDF: 255

Original Articles

All Items

flyer

authors

reviewers

indexing

Categories

aice

Keywords